Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

193

All

ATC	Name	B/G	Ingredients	Form	Price
G04BE30	LIF-DOL	B	Yohimbin HCl - 3.3mg, Thiamine - 5.5mg, Cyanocobalamine - 0.015mg, Ferrous fumarate - 50mg, Sildenafil citrate - 10mg	Tablet, coated	231,653 L.L
J07AL02	VAXNEUVANCE	B	Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant -	Injectable suspension	6,988,413 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l	Injectable solution	744,140 L.L
D10AF51	DUAC ONCE DAILY	B	Clindamycin (phosphate) - 1%, Benzoyl peroxide - 5%	Gel	1,658,302 L.L
G04BX	ROWATINEX	B	Olive oil - 33mg, Cineol - 3mg, Fenchone - 4mg, Anethol - 4mg, Borneol - 10mg, Camphene - 15mg, ?-Pinene - 6.2mg, ?-Pinene - 24.8mg	Capsule	255,330 L.L
R05DA20	ALGOMIEL COUGH SYRUP	G	Dextromethorphan HBr - 5mg, Carbinoxamine maleate - 2mg	Syrup	639,925 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l	Injectable solution	744,140 L.L
J07AP03	TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT)	B	Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml	Injectable suspension	4,020,777 L.L
S03AA30	SULFACHLOR	G	Sulfacetamide sodium - 110mg/ml, Chloramphenicol - 5mg/ml	Drops solution	202,216 L.L
B05DA	EXTRANEAL (ICODEXTRIN 7.5%) TWIN BAG	B	Sodium lactate - 4.5g/l, Magnesium Chloride - 0.051g/l, Calcium chloride - 0.257g/l, Sodium chloride - 5.4g/l, Icodextrin - 75.0 g/l	Injectable solution	1,998,025 L.L
S03CA04	MYCICORT	G	Hydrocortisone acetate - 5mg, Neomycin sulfate - 5mg	Drops suspension	166,381 L.L
B05DA	EXTRANEAL (ICODEXTRIN 7.5%) SINGLE BAG	B	Sodium lactate - 4.5g/l, Magnesium Chloride - 0.051g/l, Calcium chloride - 0.257g/l, Sodium chloride - 5.4g/l, Icodextrin - 75.0 g/l	Injectable solution	1,998,025 L.L
J07AX	BRONCHO-VAXOM CHILDREN	B	Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis - 3.5mg	Capsule	1,988,887 L.L
V01AA	STALORAL	B	Allergen extracts - 2 x 100IR ou IC/ml	Solution	8,449,319 L.L
B03AD	MALTOFER FOL	B	Folic acid - 0.35mg, Iron trivalent (hydroxide polymaltose) - 100mg	Tablet, chewable	854,684 L.L
J07AX	BRONCHO-VAXOM ADULTS	B	Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis - 7mg	Capsule	2,746,814 L.L
V01AA	STALORAL	B	Allergen extracts - 300 IR ou IC/ml	Solution	6,598,267 L.L
B03AD	EURO-FER CF	G	Folic acid - 0.5mg, Vitamin C - 200mg, Ferrous fumarate - 300mg	Capsule	706,861 L.L
B05DB	DIANEAL PD4 CYCLER 1.36% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 13.6g/l	Injectable solution	1,150,329 L.L
C05BX51	DOXIPROCT	B	Calcium dobesilate - 4%, Lidocaine HCl - 2%	Ointment	610,104 L.L
B03AD	VITA-FERIN C	G	Ferrous fumarate - 300mg, Folic acid - 0.5mg, Vitamin C - 200mg	Capsule	716,268 L.L
B05DB	DIANEAL PD4 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l	Injectable solution	1,163,270 L.L
C05BX51	DOXIPROCT PLUS	B	Calcium dobesilate - 4%, Dexamethasone acetate - 0.0025%, Lidocaine HCl - 2%	Ointment	489,159 L.L
J07BB01	INFLUVAC TETRA	B	Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml	Injectable suspension	970,254 L.L
B03AD	VITEXFER	G	Folic acid - 1mg, Ascorbic acid - 200mg, Iron ferrous fumarate - 100mg	Tablet, film coated	791,523 L.L
B05DB	DIANEAL PD4 CYCLER 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l	Injectable solution	1,150,329 L.L
G04BX14	PRIXETIN 60	G	Dapoxetine (hydrochloride) - 60mg	Tablet, film coated	1,479,123 L.L
J07BB01	VAXIGRIPTETRA, VACCIN GRIPPAL QUADRIVALENT (INACTIVE A VIRION FRAGMENTE)	B	Influenza vaccine virus (inactivated, split) - 15mcg/4strains/0.5ml	Injectable suspension	970,254 L.L
V01AA	DIATER	B	Allergen extracts -	Spray	26,856,672 L.L
B03AD03	GYNO-TARDYFERON	B	Folic acid - 0.35mg, Ferrous (sulfate) - 80mg	Tablet, sugar coated, slow release	819,744 L.L

...

193